featured
Risks of Basal Cell and Squamous Cell Carcinoma After Treatment of Psoriasis With Biologic vs Non-Biologic Systemic Therapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risks of Basal Cell and Squamous Cell Carcinoma in Psoriasis Patients After Treatment With Biologic vs Non-Biologic Systemic Therapies
J Eur Acad Dermatol Venereol 2021 Apr 18;[EPub Ahead of Print], KJ Mason, AD Burden, JNWN Barker, M Lunt, H Ali, CE Kleyn, K McElhone, MM Soliman, AC Green, CEM Griffiths, NJ Reynolds, AD Ormerod, BADBIR Study GroupFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.